Laurent Christian L Leclercq

Title: Innovations of Laurent Christian L Leclercq

Introduction

Laurent Christian L Leclercq is a notable inventor based in Liège, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes related to various disorders.

Latest Patents

Leclercq holds a patent for inhibitors of the phosphodiesterase 10 enzyme. This invention involves novel imidazo[1,2-b]pyridazine and imidazo[1,2-a]-pyrazine derivatives. These compounds are designed to be useful in the treatment or prevention of neurological, psychiatric, and metabolic disorders where the PDE10 enzyme plays a crucial role. The patent also covers pharmaceutical compositions that include these compounds, as well as processes for their preparation and their applications in medical treatments.

Career Highlights

Leclercq is associated with Beerse Pharmaceutica NV, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing effective treatments for complex health issues, showcasing his commitment to advancing medical science.

Collaborations

Some of his notable coworkers include José Manuel Bartolomé-Nebreda and Susana Conde-Ceide. Their collaborative efforts contribute to the ongoing research and development in the field of pharmaceuticals.

Conclusion

Laurent Christian L Leclercq's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in enzyme inhibitors, hold promise for improving treatment options for various disorders.